Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 280

1.

Open letter to Lady Scotland.

Weller D, Lodge M, Eden T, Fleming D, Bouffet E, Schocken C, Magrath I, Rosser J, Joubert E, Rodriguez-Galindo C, Denny L, Vallejo-Auste C; signatories.

Lancet Oncol. 2017 Apr;18(4):e194. doi: 10.1016/S1470-2045(17)30205-X. No abstract available.

PMID:
28368256
2.

Structural Barriers to Diagnosis and Treatment of Cancer in Low- and Middle-Income Countries: The Urgent Need for Scaling Up.

Cazap E, Magrath I, Kingham TP, Elzawawy A.

J Clin Oncol. 2016 Jan 1;34(1):14-9. doi: 10.1200/JCO.2015.61.9189. Epub 2015 Nov 17. Review.

3.

The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries.

Coleman CN, Formenti SC, Williams TR, Petereit DG, Soo KC, Wong J, Chao N, Shulman LN, Grover S, Magrath I, Hahn S, Liu FF, DeWeese T, Khleif SN, Steinberg M, Roth L, Pistenmaa DA, Love RR, Mohiuddin M, Vikram B.

Front Oncol. 2014 Nov 19;4:333. doi: 10.3389/fonc.2014.00333. eCollection 2014. Review.

4.

Cancer in adolescents and young adults in countries with limited resources.

Magrath I, Epelman S.

Curr Oncol Rep. 2013 Aug;15(4):332-46. doi: 10.1007/s11912-013-0327-3. Review.

PMID:
23832788
5.

Planning cancer control--the view of an NGO.

Epelman S, Magrath I.

Lancet Oncol. 2013 Apr;14(5):388-90. doi: 10.1016/S1470-2045(13)70090-1. No abstract available.

PMID:
23628186
6.

Paediatric cancer in low-income and middle-income countries.

Magrath I, Steliarova-Foucher E, Epelman S, Ribeiro RC, Harif M, Li CK, Kebudi R, Macfarlane SD, Howard SC.

Lancet Oncol. 2013 Mar;14(3):e104-16. doi: 10.1016/S1470-2045(13)70008-1. Epub 2013 Feb 20.

PMID:
23434340
7.

New policies to address the global burden of childhood cancers.

Sullivan R, Kowalczyk JR, Agarwal B, Ladenstein R, Fitzgerald E, Barr R, Steliarova-Foucher E, Magrath I, Howard SC, Kruger M, Valsecchi MG, Biondi A, Grundy P, Smith MA, Adamson P, Vassal G, Pritchard-Jones K.

Lancet Oncol. 2013 Mar;14(3):e125-35. doi: 10.1016/S1470-2045(13)70007-X. Epub 2013 Feb 20. Review.

PMID:
23434339
8.

Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease.

Ngoma T, Adde M, Durosinmi M, Githang'a J, Aken'Ova Y, Kaijage J, Adeodou O, Rajab J, Brown BJ, Leoncini L, Naresh K, Raphael M, Hurwitz N, Scanlan P, Rohatiner A, Venzon D, Magrath I.

Br J Haematol. 2012 Sep;158(6):749-62. doi: 10.1111/j.1365-2141.2012.09236.x. Epub 2012 Jul 30.

9.

Aggressive B-cell lymphomas.

Naresh KN, Magrath I, Raphael M, Leoncini L.

Adv Hematol. 2012;2012:604603. doi: 10.1155/2012/604603. Epub 2012 Mar 14. No abstract available.

10.
11.

Epidemiology: clues to the pathogenesis of Burkitt lymphoma.

Magrath I.

Br J Haematol. 2012 Mar;156(6):744-56. doi: 10.1111/j.1365-2141.2011.09013.x. Epub 2012 Jan 20. Review.

PMID:
22260300
12.

Diagnosis of Burkitt lymphoma using an algorithmic approach--applicable in both resource-poor and resource-rich countries.

Naresh KN, Ibrahim HA, Lazzi S, Rince P, Onorati M, Ambrosio MR, Bilhou-Nabera C, Amen F, Reid A, Mawanda M, Calbi V, Ogwang M, Rogena E, Byakika B, Sayed S, Moshi E, Mwakigonja A, Raphael M, Magrath I, Leoncini L.

Br J Haematol. 2011 Sep;154(6):770-6. doi: 10.1111/j.1365-2141.2011.08771.x. Epub 2011 Jul 1.

PMID:
21718280
13.

Lymphomas in sub-Saharan Africa--what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?

Naresh KN, Raphael M, Ayers L, Hurwitz N, Calbi V, Rogena E, Sayed S, Sherman O, Ibrahim HA, Lazzi S, Mourmouras V, Rince P, Githanga J, Byakika B, Moshi E, Durosinmi M, Olasode BJ, Oluwasola OA, Akang EE, Akenòva Y, Adde M, Magrath I, Leoncini L.

Br J Haematol. 2011 Sep;154(6):696-703. doi: 10.1111/j.1365-2141.2011.08772.x. Epub 2011 Jun 28. Review.

14.

Childhood T-lineage acute lymphoblastic leukemia: management and outcome at a tertiary care center in North India.

Arya LS, Padmanjali KS, Sazawal S, Saxena R, Bhargava M, Kulkarni KP, Adde M, Magrath I.

Indian Pediatr. 2011 Oct;48(10):785-90. Epub 2011 Mar 15.

PMID:
21555798
15.

Epidemiology and management of lymphoma in low-income countries.

Zucca E, Rohatiner A, Magrath I, Cavalli F.

Hematol Oncol. 2011 Mar;29(1):1-4. doi: 10.1002/hon.945.

PMID:
21381073
16.

Cancer funding in developing countries: the next health-care crisis?

Magrath I, Bey P, Shad A, Sutcliffe S.

Lancet. 2010 Nov 27;376(9755):1827. doi: 10.1016/S0140-6736(10)62168-X. No abstract available.

PMID:
21111907
17.

The World Cancer Declaration: is the world catching up?

Adams C, Grey N, Magrath I, Miller A, Torode J.

Lancet Oncol. 2010 Nov;11(11):1018-20. doi: 10.1016/S1470-2045(10)70228-X. Epub 2010 Sep 21. No abstract available.

PMID:
20864403
18.

Pattern of relapse in childhood ALL: challenges and lessons from a uniform treatment protocol.

Arya LS, Kotikanyadanam SP, Bhargava M, Saxena R, Sazawal S, Bakhshi S, Khattar A, Kulkarni KP, Adde M, Vats TS, Magrath I.

J Pediatr Hematol Oncol. 2010 Jul;32(5):370-5. doi: 10.1097/MPH.0b013e3181d7ae0d.

PMID:
20463606
19.

Organization of population-based cancer control programs: Europe and the world.

Otter R, Qiao YL, Burton R, Samiei M, Parkin M, Trapido E, Weller D, Magrath I, Sutcliffe S; ICCC-3 Session E Group.

Tumori. 2009 Sep-Oct;95(5):623-36.

PMID:
19999952
20.

Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens.

Kelly JL, Toothaker SR, Ciminello L, Hoelzer D, Holte H, LaCasce AS, Mead G, Thomas D, Van Imhoff GW, Kahl BS, Cheson BD, Magrath IT, Fisher RI, Friedberg JW.

Clin Lymphoma Myeloma. 2009 Aug;9(4):307-10. doi: 10.3816/CLM.2009.n.060.

21.

It is time to include cancer and other noncommunicable diseases in the millennium development goals.

Seffrin JR, Hill D, Burkart W, Magrath I, Badwe RA, Ngoma T, Mohar A, Grey N.

CA Cancer J Clin. 2009 Sep-Oct;59(5):282-4. doi: 10.3322/caac.20033. Epub 2009 Aug 14. No abstract available.

22.

Lessons from clinical trials in African Burkitt lymphoma.

Magrath I.

Curr Opin Oncol. 2009 Sep;21(5):462-8. doi: 10.1097/CCO.0b013e32832f3dcd. Review.

PMID:
19620863
23.

Non-communicable diseases. Please redress the balance of millennium development goals.

Magrath I, Seffrin J, Hill D, Burkart W, Badwe RA, Ngoma T.

BMJ. 2009 Jun 23;338:b2533. doi: 10.1136/bmj.b2533. No abstract available. Erratum in: BMJ. 2009;339:b2770.

PMID:
19549662
24.

Denis Burkitt and the African lymphoma.

Magrath I.

Ecancermedicalscience. 2009;3:159. doi: 10.3332/ecancer.2009.159. Epub 2009 Sep 30.

25.

Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study.

Ribeiro RC, Steliarova-Foucher E, Magrath I, Lemerle J, Eden T, Forget C, Mortara I, Tabah-Fisch I, Divino JJ, Miklavec T, Howard SC, Cavalli F.

Lancet Oncol. 2008 Aug;9(8):721-9. doi: 10.1016/S1470-2045(08)70194-3.

26.

Building capacity for cancer control in developing countries: the need for a paradigm shift.

Magrath I.

Lancet Oncol. 2007 Jul;8(7):562-3. No abstract available.

PMID:
17613415
27.

Treatment of Burkitt lymphoma in children and adults: Lessons from Africa.

Magrath IT.

Curr Hematol Malig Rep. 2006 Dec;1(4):230-40. doi: 10.1007/s11899-006-0004-9. Review.

PMID:
20425318
28.

High level expression of N-acetylgluosamine-6-O-sulfotransferase is characteristic of a subgroup of paediatric precursor-B acute lymphoblastic leukaemia.

Timson G, Banavali S, Gutierrez MI, Magrath I, Bhatia KG, Goyns MH.

Cancer Lett. 2006 Oct 28;242(2):239-44. Epub 2005 Dec 28.

PMID:
16386360
29.

Role of the global civil society.

Magrath I.

Lancet. 2005 Aug 20-26;366(9486):613-5. No abstract available.

PMID:
16112285
30.

Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].

Magrath I, Shanta V, Advani S, Adde M, Arya LS, Banavali S, Bhargava M, Bhatia K, Gutiérrez M, Liewehr D, Pai S, Sagar TG, Venzon D, Raina V.

Eur J Cancer. 2005 Jul;41(11):1570-83. Epub 2005 Jan 5. Review. Erratum in: Eur J Cancer. 2007 Feb;43(3):632. Raina, V [added].

PMID:
16026693
31.

Report of an International Network of Cancer Treatment and Research workshop on non-Hodgkin's lymphoma in developing countries.

Naresh KN, Advani S, Adde M, Aziz Z, Banavali S, Bhatia K, Belgaumi A, Ezzat A, Khaled H, Mokhtar N, Norton A, Rohatiner A, Sagar TG, Taciyliz N, Temmim L, Venkatesh C, Yan Tang J, Magrath I.

Blood Cells Mol Dis. 2004 Nov-Dec;33(3):330-7.

PMID:
15528153
32.

Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation.

Hussain A, Gutiérrez MI, Timson G, Siraj AK, Deambrogi C, Al-Rasheed M, Gaidano G, Magrath I, Bhatia K.

Genes Chromosomes Cancer. 2004 Dec;41(4):321-9.

PMID:
15384174
33.

Differences in the expression of apoptotic proteins in Burkitt's lymphoma cell lines: potential models for screening apoptosis-inducing agents.

Doucet JP, Hussain A, Al-Rasheed M, Gaidano G, Gutiérrez MI, Magrath I, Bhatia K.

Leuk Lymphoma. 2004 Feb;45(2):357-62.

PMID:
15101724
34.

Chemotherapy in developing countries--is less better?

Magrath I.

Eur J Cancer. 2003 Jul;39(11):1497-500. No abstract available.

PMID:
12855254
35.

Frequencies of the major subgroups of precursor B-cell acute lymphoblastic leukemia in Indian children differ from the West.

Siraj AK, Kamat S, Gutiérrez MI, Banavali S, Timpson G, Sazawal S, Bhargava M, Advani S, Adde M, Magrath I, Bhatia K.

Leukemia. 2003 Jun;17(6):1192-3. No abstract available.

PMID:
12764391
36.

Molecular characteristics of diffuse large-B-cell lymphoma.

Magrath I.

N Engl J Med. 2002 Jun 20;346(25):1998-9. No abstract available.

PMID:
12075062
37.

Expression of P53 and bcl-2 proteins in T-cell lymphoblastic lymphoma: prognostic implications.

Naresh KN, Banavali SD, Bhatia KG, Magrath I, Soman CS, Advani SH.

Leuk Lymphoma. 2002 Feb;43(2):333-7.

PMID:
11999565
38.

Burkitt's/Burkitt's-like lymphoma presenting as bacterial sinusitis in two HIV-infected children.

Robinson MR, Salit RB, Bryant-Greenwood PK, Zeichner SL, Wood LV, Jaffe ES, van Waes C, Magrath IT.

AIDS Patient Care STDS. 2001 Sep;15(9):453-8.

PMID:
11587630
40.

Pediatric oncology in developing countries: development of an alliance of stakeholders.

Naafs-Wilstra M, Barr R, Greenberg C, Magrath I, Cardenas F, Chesler M, Masera G, Davis A, Barun K, Morrison H, Petrilli S.

Med Pediatr Oncol. 2001 Feb;36(2):305-9. No abstract available.

PMID:
11452939
41.

Increased level of stromal cell-derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma.

Sei S, O'Neill DP, Stewart SK, Yang Q, Kumagai M, Boler AM, Adde MA, Zwerski SL, Wood LV, Venzon DJ, Magrath IT.

Cancer Res. 2001 Jul 1;61(13):5028-37.

42.

Expression of EBV encoded nuclear small non-polyadenylated RNA (EBER) molecules in 32 cases of childhood Burkitt's lymphoma from Israel.

Peylan-Ramu N, Diment J, Krichevsky S, Ben-Yehuda D, Bhatia K, Magrath IT.

Leuk Lymphoma. 2001 Jan;40(3-4):405-11.

PMID:
11426563
43.

Incidence, clinical characteristics and early treatment outcome in Indian patients of childhood acute lymphoblastic leukemia with ALL-1 gene rearrangement.

Sazawal S, Gurbuxani S, Bhatia K, Khattar A, Raina V, Arya LS, Vats T, Magrath I, Bhargava M.

Leuk Res. 2001 Aug;25(8):693-8.

PMID:
11397475
44.

Association of Burkitt's lymphoma with the Epstein-Barr virus in two developing countries.

Rao CR, Gutierrez MI, Bhatia K, Fend F, Franklin J, Appaji L, Gallo G, O'Conor G, Lalitha N, Magrath I.

Leuk Lymphoma. 2000 Oct;39(3-4):329-37.

PMID:
11342313
45.

Significance of MDR1, MRP1, GSTpi and GSTmu mRNA expression in acute lymphoblastic leukemia in Indian patients.

Gurbuxani S, Singh Arya L, Raina V, Sazawal S, Khattar A, Magrath I, Marie J, Bhargava M.

Cancer Lett. 2001 Jun 10;167(1):73-83.

PMID:
11323101
46.

Impact of chemotherapy for AIDS-related malignancies in pediatric HIV disease.

Gonzalez CE, Adde M, Taylor P, Wood LV, Magrath I.

Ann N Y Acad Sci. 2000 Nov;918:362-6. No abstract available.

PMID:
11131726
47.

Pattern of immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements in childhood acute lymphoblastic leukemia in India.

Sazawal S, Bhatia K, Gurbuxani S, Singh Arya L, Raina V, Khattar A, Vats T, Magrath I, Bhargava M.

Leuk Res. 2000 Jul;24(7):575-82.

PMID:
10867131
48.

Discrepancies in Epstein-Barr virus association at presentation and relapse of classical Hodgkin's disease: impact on pathogenesis.

Nerurkar AY, Vijayan P, Srinivas V, Soman CS, Dinshaw KA, Advani SH, Magrath I, Bhatia K, Naresh KN.

Ann Oncol. 2000 Apr;11(4):475-8.

PMID:
10847469
49.

Association of EBV strains, defined by multiple loci analyses, in non-Hodgkin lymphomas and reactive tissues from HIV positive and HIV negative patients.

Gutiérrez MI, Kingma DW, Sorbara L, Tran M, Raffeld M, Jaffe ES, Magrath I, Bhatia K.

Leuk Lymphoma. 2000 Apr;37(3-4):425-9.

PMID:
10752994
50.

Loss of Y chromosome in bilharzial bladder cancer.

Khaled HM, Aly MS, Magrath IT.

Cancer Genet Cytogenet. 2000 Feb;117(1):32-6.

PMID:
10700863

Supplemental Content

Loading ...
Support Center